Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease

Citation
E. Iseki et al., Degenerative terminals of the perforant pathway are human alpha-synuclein-immunoreactive in the hippocampus of patients with diffuse Lewy body disease, NEUROSCI L, 258(2), 1998, pp. 81-84
Citations number
18
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
258
Issue
2
Year of publication
1998
Pages
81 - 84
Database
ISI
SICI code
0304-3940(199812)258:2<81:DTOTPP>2.0.ZU;2-9
Abstract
We investigated the hippocampal pathology in diffuse Lewy body disease (DLB D) using alpha-synuclein immunohistochemistry. Ubiquitin-positive intrahipp ocampal structures caused by the degeneration of terminal axons of the perf orant pathway were observed to be alpha-synuclein immunoreactive. These alp ha-synuclein-positive degenerative terminals contained granulo-filamentous or vesiculo-tubular components similar to those of Lewy bodies (LB) immunoe lectron microscopically, suggesting that alpha-synuclein may abnormally agg regate into filamentous or membranous cytoskeletal components including neu rofilaments and synaptic vesicles in DLBD. A 'dying back' degenerating proc ess due to a blockage of axonal transport may explain why the degenerative terminals and LB share similar alpha-synuclein-positive components, but the origin cells of the perforant pathway contain only a few LB. (C) 1998 Else vier Science Ireland Ltd. All rights reserved.